Chaoju Ophthalmology (02219) announced results for the year ended December 31, 2023, with revenue of 1,369.5 billion...
According to Zhitong Finance App News, Chaoju Ophthalmology (02219) announced results for the year ended December 31, 2023, with revenue of $1,369.5 million (RMB, same below), up 38.3% year on year; profit attributable to parent company owners of $229 million, up 21.9% year on year; basic profit of $0.33 per share, proposed final dividend of HK$0.2208 per share and special dividend of HK$0.0767 per share.
The Group's revenue increased 38.3% year over year, mainly due to the recovery in demand for ophthalmology services, the Group's ability to receive increased patient visits, industry recovery, and improvements in China's post-COVID-19 economic environment.
As of December 31, 2023, the Group operated a network of 31 ophthalmology hospitals and 29 optometry centers, spanning a total of seven provinces and autonomous regions in China. Ophthalmology hospitals specialize in ophthalmology services, while optometry centers provide a range of optometry products and services to meet the various needs of customers.